Oklahoma Medical Research Foundation; MS Center of Excellence
825 Northeast 13th Street
Oklahoma City, Oklahoma 73104
Oklahoma City, Oklahoma 73104
We've found
4 trials
at this facility
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis (MS) Clinical Trial
Updated: 12/31/1969
Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials